A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.
Also called NCT05355948
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 1,000 participants
- Sponsor
- Registry
-
NCT05355948
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05355948. Randomized; no masking; primary purpose prevention. Start 2022-05-09 (actual); primary completion 2023-07-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke
- Acronym
- MEMO-DAF8
- Condition
- Atrial Fibrillation/Flutter in Patients With High Risk of Stroke
- Intervention (Device)
- MEMO Patch PLUS for 1 day
- Intervention (Device)
- MEMO Patch PLUS for More than 8-days
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct05355948- Content hash
4ad180f7ff41aab3eff94b3892b68b6a8018a18b29c89a960a1010ea0e474286